BeiGene Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SHSC:6160 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Sep 24	BuyHK$43,680,325	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	362,816	HK$120.39
27 Aug 24	SellHK$2,963,845	John Oyler	Individual	24,479	HK$121.08
01 Jul 24	SellHK$530,615	Julia Wang	Individual	472	HK$1,124.19
14 Jun 24	SellHK$179,217,653	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	1,814,866	HK$98.75
19 Apr 24	BuyHK$134,126	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	1,749	HK$76.69
10 Apr 24	SellHK$31,165,360	John Oyler	Individual	347,308	HK$89.73
09 Apr 24	SellHK$13,500,329	John Oyler	Individual	145,600	HK$92.72
26 Mar 24	SellHK$2,925,744	John Oyler	Individual	31,681	HK$92.35
12 Mar 24	SellHK$48,338,194	John Oyler	Individual	489,684	HK$98.71
14 Nov 23	BuyHK$1,718,913,641	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	14,455,914	HK$118.91
08 Nov 23	SellHK$111,614,052	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	923,715	HK$120.83
24 Oct 23	BuyHK$42,655,711	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	425,063	HK$100.35

Insider Buying: 6160 insiders have only sold shares in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 79.2% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
17.8%	Amgen Inc.	18,938,119	HK$30.5b	-50%	no data
9.95%	Baker Bros. Advisors LP	10,576,082	HK$17.0b	0%	20.07%
9.66%	HHLR Advisors, Ltd.	10,274,222	HK$16.5b	0%	26.15%
7.85%	Capital Research and Management Company	8,345,978	HK$13.4b	0.02%	0.08%
4.87%	Hillhouse Investment Management, Ltd.	5,176,906	HK$8.3b	0%	9.07%
4.69%	PRIMECAP Management Company	4,986,289	HK$8.0b	-0.31%	0.7%
3.91%	John Oyler	4,159,140	HK$6.7b	15.1%	no data
3.64%	Baillie Gifford & Co.	3,870,330	HK$6.2b	-1.94%	0.34%
2.83%	Temasek Holdings (Private) Limited	3,014,171	HK$4.8b	0%	0.47%
2.62%	BlackRock, Inc.	2,785,050	HK$4.5b	-1.58%	0.01%
2.14%	T. Rowe Price Group, Inc.	2,273,068	HK$3.7b	12.2%	0.04%
1.85%	The Vanguard Group, Inc.	1,964,564	HK$3.2b	0.41%	0.01%
1.53%	FMR LLC	1,625,848	HK$2.6b	-0.92%	0.02%
1.08%	Bosera Asset Management Co., Ltd.	1,152,202	HK$1.9b	-8.01%	1.29%
0.82%	Xiaodong Wang	876,794	HK$1.4b	-3.01%	no data
0.67%	GF Fund Management Co., Ltd.	713,943	HK$1.1b	-15.8%	0.37%
0.47%	Tavistock Life Sciences	500,000	HK$804.1m	0%	5.01%
0.42%	China Asset Management Co. Ltd.	444,136	HK$714.3m	-0.52%	0.15%
0.37%	ICBC Credit Suisse Asset Management Co., Ltd.	398,055	HK$640.2m	-25.4%	0.58%
0.36%	Point72 Asset Management, L.P.	381,382	HK$613.4m	0%	0.18%
0.35%	Guangzhou Development District Holding Group Limited	368,385	HK$592.5m	0%	no data
0.35%	SDIC Unity Capital Co., Ltd.	368,385	HK$592.5m	0%	7.22%
0.33%	Public Investment Fund	354,385	HK$570.0m	0%	0.01%
0.33%	Vestal Point Capital, LP	350,000	HK$562.9m	7.69%	4.71%
0.29%	Wanjia Asset Management Co., Ltd.	307,600	HK$494.7m	0%	1.11%